Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease

British Journal of Dermatology

Volumn 163, Issue 1, 2010, Pages 197-200

  Hanneken, S ^a   Rutten A ^b   Pasternack, S M ^c   Eigelshoven, S ^a   El Shabrawi Caelen, L ^d   Wenzel, J ^c   Braun Falco, M ^e   Ruzicka, T ^a,e   Nothen M M ^c   Kruse, R ^a   Betz, R C ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b Dermatopathologische Gemeinschaftspraxis   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Dowling Degos disease; Galli Galli disease; KRT5; reticulate pigmentation

Indexed keywords

CYTOKERATIN 5;

ACANTHOLYSIS; ARTICLE; CLINICAL ARTICLE; DOWLING DEGOS DISEASE; GALLI GALLI DISEASE; GENE MUTATION; GENE SEQUENCE; GENODERMATOSIS; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ACANTHOLYSIS; ADOLESCENT; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERPIGMENTATION; KERATIN-5; MALE; MALIGNANT ATROPHIC PAPULOSIS; MUTATION; PEDIGREE; YOUNG ADULT;

EID: 77954015882     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09741.x     Document Type: Article

References (16)

1. El Shabrawi-Caelen L, Ruetten A, Kerl H. The expanding spectrum of Galli-Galli disease. J Am Acad Dermatol 2007 56 : S86 91.
2. Gilchrist H, Jackson S, Morse L et al. Galli-Galli disease: a case report with review of the literature. J Am Acad Dermatol 2008 58 : 299 302.
3. Mittag H, Rupec M, Klingmüller G. Der Morbus Galli-Galli - eine Entität? Akt Dermatol 1986 12 : 41 6.
4. Bardach H, Gebhart W, Luger T. Genodermatosis in a pair of brothers: Dowling-Degos, Grover, Darier, Hailey-Hailey or Galli-Galli disease? (In German) Hautarzt 1982 33 : 378 383.
5. Braun-Falco M, Volgger W, Borelli S et al. Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease? J Am Acad Dermatol 2001 45 : 760 763.
6. De Deene A, Schulze H. Morbus Galli-Galli: eine Variante des Morbus Darier? H+G Zeitschrift für Hautkrankheiten 1996 71 : 860 862.
7. El Shabrawi-Caelen L, Hofer A, Kerl H. Macro-micro dermatology: erythematous papules and lentigo-like macules - a new entity? J Dtsch Dermatol Ges 2007 5 : 645 646.
8. Krönert C, Schönlebe J. Morbus Galli-Galli. Akt Dermatol 2006 32 : 388 399.
9. Müller CS, Pföhler C, Tilgen W. Changing a concept - controversy on the confusing spectrum of the reticulate pigmented disorders of the skin. J Cutan Pathol 2009 36 : 44 8.
10. Rütten A, Strauß T. Morbus Galli-Galli: a further case report. Akt Dermatol 1995 21 : 255 257.
11. Sprecher E, Indelman M, Khamaysi Z et al. Galli-Galli disease is an acantholytic variant of Dowling-Degos disease. Br J Dermatol 2007 156 : 572 574.
12. Betz RC, Planko L, Eigelshoven S et al. Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am J Hum Genet 2006 78 : 510 519.
13. Milde P, Süss R, Megahed M et al. Morbus Dowling-Degos-Kitamura. H+G Zeitschrift für Hautkrankheiten 1994 69 : 282 283.
14. Wenzel J, Tappe K, Gerdsen R et al. Successful treatment of Dowling-Degos disease with Er : YAG laser. Dermatol Surg 2002 28 : 748 750.
15. Braun-Falco M, Ring J. Enhanced cytoplasmic expression of desmocollin 3 in epidermal rete ridges of Dowling-Degos syndrome. Br J Dermatol 2003 149 : 1293 1296.
16. Asahina A, Ishii N, Kai H et al. Dowling-Degos disease with asymmetrical distribution and no KRT 5 exon 1 mutation. Acta Derm Venereol 2007 87 : 556 557.